Department of Internal Medicine
J. Andrew Bertolatus, M.D.
Dr. Bertolatus' interests are in the area of clinical trials, clinical investigations in the area of renal transplantation, and protection of human subjects in research. Some of his areas of emphasis and interest include:
Sirolimus (rapamycin): he has been involved with several multicenter trials which have established the efficacy of this new, non-nephrotoxic immunosuppressive drug in renal transplantation. He is currently participating in an ongoing multicenter trial with this drug.
Dr. Bertolatus has a longstanding interest in the area of living kidney donors. Particular areas of emphasis have included a) evaluation of kidney function in potential kidney donors; b) long term consequences of kidney donation c) effect of donor kidney function on recipient outcome. He is in the process of assembling a University of Iowa donor database to facilitate further research in this area.
Dr. Bertolatus also has a major commitment to the area of protection of human subjects in research. Since 2000 he has been a co-chair of the University of Iowa Biomedical Institutional Review Board (IRB). He is also a member of the Council on Accreditation of the Association for Accreditation of Human Research Protection Programs (AAHRPP), and is a frequent accreditation site visitor for this voluntary accreditation program.
Honors, Awards, and Organizations
- Diplomate, American Board of Internal Medicine and Board of Nephrology
- Fellow, American College of Physicians
- American Society of Nephrology
- American Society of Transplant Physicians
- International Society of Nephrology
- National Kidney Foundation
- Editorial Board, Progress in Transplantation
- Member, Council on Accreditation, Association for Accreditation of Human Research Protection Programs (AAHRPP)
- Member, Public Responsibility in Medicine and Research (PRIM&R)